Results 111 to 120 of about 6,382,615 (401)

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

open access: yesMolecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen   +13 more
wiley   +1 more source

A sociological approach to the history of medicine.

open access: yesMedicina e historia, 1970
WHAT HISTORY can teach is a much-discussed question and historians themselves are divided about the answer; what medical history can teach is a question which is not often asked and yet there can be little doubt about the answer. The direction of medical
T. Mckeown
semanticscholar   +1 more source

Cystic Fibrosis [PDF]

open access: yes, 2004
First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2004. ©The Trustee of the Wellcome Trust, London, 2004. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated ...
Christie, DA, Tansey, EM
core  

History at the heart of medicine

open access: yesWellcome Open Research
With a focus on the challenges of today and tomorrow in the critical medical humanities the role of history is often overlooked. Yet history and medicine are closely intertwined. Right now, with the surfacing of knotty problems such as changing demographics, chronic pain, loneliness and Long Covid – and the consequent necessity to change directions and
Richard T. Bellis   +7 more
openaire   +3 more sources

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Book review: "Medicine: The Definitive Illustrated History" by Steve Parker

open access: yesHeart Vessels and Transplantation, 2022
Andrea de Lorenzo
doaj   +1 more source

Historical outline of the cancer in the speech of the Doctors of the atlantic coast. The first half of the 20th century

open access: yesRevista Ciencias Biomédicas, 2012
The present article is result of an historical investigation of descriptive character whichfundamental aim is to show, since the review of the medical scientific publications at theend of the 20th century and the first half of the 20thcentury, the ...
Sierra-Merlano Rita   +2 more
doaj  

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Doctor Nurys Diéguez Andrés (1951-2016), mainstay of the Intensive Care Medicine in Las Tunas

open access: yesRevista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2016
Doctor Nurys Nirma Diéguez Andrés is one of the outstanding personalities in the barely four decades of universal and free medicine in the Cuban province of Las Tunas. She started her graduate studies on Internal Medicine at Dr.
Orlando Rafael Serrano Barrera
doaj  

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy